The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells
about
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsFirst phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyScaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentAnimal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Microbicides: topical prevention against HIVCandidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.Which topical microbicides for blocking HIV-1 transmission will work in the real world?Targeting Trojan Horse leukocytes for HIV prevention.Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infectionsPreclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicideCharacterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.Preclinical evaluation of lime juice as a topical microbicide candidate.HIV transmissionNovel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine modelPharmacologic opportunities for HIV prevention.Vaginal microbicides and the prevention of HIV transmissionInhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitorAdherence to anti-retroviral therapy among HIV patients in Bangalore, India.Reverse transcriptase inhibitors as potential colorectal microbicides.Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challengeMultisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.HIV sexual transmission and microbicides.The development of rectal microbicides for HIV prevention.In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.
P2860
Q21090521-3120309D-49D5-4ECD-843F-CA9E6F1442A0Q21135264-AB89CF51-3E02-4E0B-BD47-3D973CFC32F2Q24650458-00D57E78-6138-4BC4-80C5-B10B9BA16CE2Q26777022-55B04407-1820-47F9-9BC2-5C1982AAB70DQ26999403-9E3B835C-A4CB-42F6-8AE1-AB03B4151E02Q30356032-F697197D-BE1C-499A-A486-94B734BBD976Q33253661-27D59718-57F5-4D16-8F12-1C5673B2AA96Q33518390-EEEED8FA-769F-4C6A-8B50-A60AE25D0356Q33826304-4351FFF0-DAEB-49F1-9E55-37B1398F0980Q34566597-5C973A38-06A6-4C9D-BA3D-F71478B3E792Q35213456-16C3F702-B917-4778-BA84-15480D23443EQ35252587-4D147ACF-608C-4359-979A-8338A1A91998Q35759112-6D50FECF-858D-49BC-B0DB-20021F766D5BQ35808786-D8F7BB54-AEB5-4096-A8A4-F232B7734187Q35914529-6A1CE0E1-B8B6-452C-AC44-0B64DBD41ACBQ35941336-5758AB4C-22B0-4848-9152-274B140ECF96Q36018776-870526C8-3FC5-4338-BDE3-319BB9F32D8DQ36078433-302B75A0-DA94-4450-A1E0-1366998B8C6CQ36171647-6570C32F-5BCF-4D65-A2CA-3B2CF96AC971Q36325778-0A11561C-BB02-4310-8B25-7597A5A08385Q36482710-F1D0B24E-87C7-4A6F-B3C1-6FAA1FEAC98AQ36485068-AC6190EB-E535-4E49-B9C8-5DE6AEE75F4EQ36526615-A25DDE2C-CF06-4508-B9D8-2B06296F2A70Q36632128-1A582584-F74C-45AD-93D5-A23E1FD0E4B6Q36744775-6AF58268-95F5-4E96-916C-9AF30ED3A628Q36748039-D966F5AB-FB91-4727-9ADB-5EA95210DB70Q36905431-6D9BCB65-3F40-49A5-8698-BB3C078B03F5Q37063819-FE722FAF-E81C-424B-85B6-57CF91019578Q37072072-BFA07BE0-75F6-451C-B971-5F4A5686CD28Q37190597-BA327F62-2967-49F1-96B7-7C5B1CE250E7Q37190754-D4BDFFF0-C19A-43D3-839B-96497E752731Q37252676-02C0E63A-E7F2-4130-8858-8278B9B343CCQ37410434-7D185AB2-BEE4-4D5D-BEBD-155ED0B93271Q37428359-F262BAB6-8B95-4FC2-8F2E-42A161523DD8Q37512871-BD3D9FCA-EB0A-4142-86D5-CA8E889E8531Q37853935-AEBB6093-0A5D-433C-B30B-94EE3442948CQ38165222-FF861B81-D97B-4372-BA6E-DF654B998BDEQ39518073-B12CE234-6DAF-4462-B6F1-B273C27FA96DQ39808350-9765926A-385A-4BDE-8D07-1BB9DF07A631Q40081674-0A6BC1DE-E53F-4ACD-AFD1-CD8154943CB0
P2860
The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The nonnucleoside reverse tran ...... ssemination by migratory cells
@ast
The nonnucleoside reverse tran ...... ssemination by migratory cells
@en
type
label
The nonnucleoside reverse tran ...... ssemination by migratory cells
@ast
The nonnucleoside reverse tran ...... ssemination by migratory cells
@en
prefLabel
The nonnucleoside reverse tran ...... ssemination by migratory cells
@ast
The nonnucleoside reverse tran ...... ssemination by migratory cells
@en
P2093
P2860
P1433
P1476
The nonnucleoside reverse tran ...... ssemination by migratory cells
@en
P2093
George Griffin
Greg Wallace
Joseph Romano
Leonid Margolis
Patricia Fletcher
Yana Kiselyeva
P2860
P304
11179-11186
P356
10.1128/JVI.79.17.11179-11186.2005
P407
P577
2005-09-01T00:00:00Z